Nigel S Key Selected Research

Reticulocytosis

11/2020	Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease.
6/2018	Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nigel S Key Research Topics

Disease

40	Hemorrhage 01/2022 - 07/2002
28	Thrombosis (Thrombus) 01/2022 - 11/2002
27	Hemophilia A (Haemophilia) 01/2022 - 07/2002
25	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2007
22	Inflammation (Inflammations) 01/2021 - 06/2004
17	Neoplasms (Cancer) 01/2021 - 06/2010
17	Venous Thromboembolism 12/2020 - 11/2002
8	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2004
7	Hemolysis 11/2020 - 02/2011
6	Thrombophilia 01/2022 - 11/2002
5	Sickle Cell Trait 07/2020 - 06/2009
5	Venous Thrombosis (Deep-Vein Thrombosis) 02/2016 - 02/2009
3	COVID-19 01/2022 - 01/2020
3	Hypertension (High Blood Pressure) 01/2021 - 10/2014
3	Wounds and Injuries (Trauma) 01/2021 - 07/2010
3	Infections 05/2020 - 07/2010
3	Hemophilia B (Haemophilia B) 01/2020 - 01/2012
3	Stroke (Strokes) 01/2020 - 01/2012
3	Pain (Aches) 07/2019 - 10/2011
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 08/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 06/2012
3	Anemia 11/2018 - 12/2004
3	Ischemic Stroke 07/2016 - 10/2014
3	von Willebrand Diseases (von Willebrand's Disease) 06/2015 - 09/2005
3	Multiple Myeloma 02/2015 - 07/2010
2	Polycythemia Vera 01/2022 - 01/2019
2	Body Weight (Weight, Body) 01/2022 - 03/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2021 - 11/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 07/2012
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 01/2020
2	Reticulocytosis 11/2020 - 06/2018
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 10/2014
2	Diabetes Mellitus 09/2019 - 10/2014
2	Thalassemia 11/2018 - 01/2012
2	Albuminuria 01/2018 - 11/2014
2	Acute Pain 01/2018 - 09/2013
2	Atrial Fibrillation 01/2016 - 10/2014
2	Pulmonary Embolism 02/2015 - 06/2013
2	Hemoglobinopathies 10/2014 - 04/2014
2	Thromboembolism 10/2014 - 08/2013

Drug/Important Bio-Agent (IBA)

21	Thromboplastin (Tissue Factor)IBA 01/2022 - 09/2003
18	Thrombin FDA Link 01/2022 - 06/2004
15	Biomarkers (Surrogate Marker)IBA 12/2020 - 10/2011
13	Hemostatics (Antihemorrhagics)IBA 03/2021 - 12/2004
11	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 11/2004
8	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2011
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
8	AnticoagulantsIBA 10/2020 - 01/2007
7	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2012
6	Heparin (Liquaemin)FDA LinkGeneric 05/2020 - 05/2012
5	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 11/2004
5	recombinant FVIIa (rFVIIa)FDA Link 12/2020 - 07/2002
5	Prothrombin (Factor II)IBA 07/2010 - 07/2002
4	Pharmaceutical PreparationsIBA 05/2020 - 05/2012
4	AlbuminsIBA 01/2020 - 11/2011
4	Dexamethasone (Maxidex)FDA LinkGeneric 02/2015 - 07/2010
3	A-factor (Streptomyces)IBA 01/2022 - 04/2007
3	AntibodiesIBA 01/2022 - 11/2004
3	Tranexamic Acid (AMCA)FDA Link 01/2022 - 01/2018
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2022 - 01/2018
3	Complement System Proteins (Complement)IBA 07/2021 - 01/2019
3	CholesterolIBA 01/2021 - 10/2014
3	AutoantibodiesIBA 12/2020 - 02/2014
3	apixabanIBA 12/2020 - 10/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 01/2012
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020 - 06/2013
3	Histones (Histone)IBA 10/2020 - 01/2017
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2020 - 11/2004
3	FibrinIBA 01/2020 - 08/2007
3	Inosine Triphosphate (ITP)IBA 01/2019 - 08/2007
3	Biological ProductsIBA 01/2019 - 02/2016
3	Factor VIIa (Activated Factor VII)IBA 07/2018 - 07/2002
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2012 - 02/2011
3	factor V LeidenIBA 07/2010 - 11/2002
2	AntithrombinsIBA 01/2022 - 05/2003
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 03/2014
2	Kallikreins (Kallikrein)IBA 01/2022 - 01/2020
2	emicizumabIBA 07/2021 - 06/2019
2	Fibrinolysin FDA Link 04/2021 - 01/2021
2	RivaroxabanIBA 01/2021 - 10/2020
2	Factor Xa InhibitorsIBA 01/2021 - 02/2020
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 01/2020
2	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2021 - 01/2020
2	edoxabanIBA 10/2020 - 02/2020
2	SelectinsIBA 01/2020 - 10/2011
2	GlobinsIBA 01/2020 - 11/2018
2	Monoclonal AntibodiesIBA 06/2019 - 10/2014
2	von Willebrand FactorIBA 01/2019 - 01/2003
2	Heme (Haem)IBA 06/2018 - 03/2015
2	CreatinineIBA 01/2018 - 11/2014
2	Eptifibatide (Integrilin)FDA Link 01/2018 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 04/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 11/2015
2	PhosphatidylserinesIBA 01/2016 - 02/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2015 - 06/2013

Therapy/Procedure

27	Therapeutics 01/2022 - 07/2002
10	Drug Therapy (Chemotherapy) 01/2022 - 07/2010
2	Renal Dialysis (Hemodialysis) 07/2021 - 04/2014
2	Resuscitation 04/2015 - 06/2013
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2015 - 02/2005